AMN (Health Care Services) Stock Valuation & Fair Value Significantly overvalued
AMN (Health Care Services) trades at a blended P/E of 16.5, about 14% below its historical normal valuation, with a forward growth estimate of -18.6% and a PEG of —. Analysts' one-year estimates have been hit 36% of the time.
Valuation flags
- Negative growth forecast
Frequently asked questions
Is AMN overvalued?
At a blended P/E of 16.5 versus its historical normal P/E of 19.2, AMN trades about 14% below its typical valuation. tickerseer currently rates it significantly overvalued.
What is AMN's fair value and PEG?
AMN trades at a blended P/E of 16.5 against a historical normal P/E of 19.2, and a forward growth estimate of -18.6%.
Has tickerseer's rating of AMN changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.